BlogHeader.png

Top 7 Benefits of the Bruker D8 DISCOVERY HTS™

The D8 DISCOVER HTS combines advanced sample analysis throughput capabilities with great flexibility. This highly innovative system perfectly matches the application requirements of the pharmaceutical industry for crystallization studies, polymorph screening, structure solution, phase identification and crystallite size determination under ambient and non-ambient conditions. With its unparalleled high-throughput screening capability, the D8 DISCOVER HTS provides opportunities for optimization of the development and production of pharmaceuticals 

This state-of-the-art equipment at Alcami's Center of Excellence for Solid State Chemistry in Weert, Netherlands enhances our end-to-end service offering, helping clients meet significant milestones and maintain stability in drug development.

Topics: Solid State

ON-DEMAND WEBINAR: Accelerating Drug Development through Automation

Join Alcami for a webinar to learn more about accelerating drug development through automation.

Drug development is based on making the right decisions at the right moment; where R&D focuses on providing that information as rapidly as possible. At Alcami, we use automation as a tool to provide the overall design space of the reaction sequence, form selection and crystallization from gram to multi-kilogram scale. The approach of combined Principle Component Analysis (PCA) and Design of Experiments (DoE) provides a broad overview, with a high diversity in conditions and optimal route for further development. The integrated process chemistry, analytics and pre-formulation allow for a parallel approach to the program that shortens timelines without the loss of information due to transfer between departments and/or companies. The seamless integration of these activities eliminates unnecessary repetition of what has worked before by secondary labs and keeps the research at Alcami focused on finding the best overall conditions to optimize quality and quantity.

Topics: Webinars Solid State

Alcami Invests in Bruker’s D8 DISCOVER HTS™ System for High-Throughput X-Ray Diffraction Screening in Pharmaceutical Formulation Development

Weert, The Netherlands and Karlsruhe, Germany – March 3, 2017 – Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, and Bruker AXS, one of the world's leading suppliers of analytical X-ray solutions, today announced the delivery of Bruker’s D8 DISCOVER HTS™ high-throughput X-ray Diffraction (XRD) analysis system to the Alcami site in Weert, The Netherlands.

Topics: Company News Solid State

Freeslate Powder Dispensing System Is Selected To Increase Solid State Capabilities

SUNNYVALE, CA & WILMINGTON, NC – September 30, 2015 – Freeslate, Inc., the leading provider of high throughput research solutions for biopharmaceutical development, today announced that AAIPharma Services Corp. / Cambridge Major Laboratories, Inc. (AAI/CML) has acquired a CM Protégé Powder Dispense System to support its existing Freeslate Core Module system for solid state screening and characterization. As Contract Development and Manufacturing Organizations (CDMOs) continue to adopt automation, AAI/CML is leading the way by deploying reliable, modular Freeslate systems dedicated to solid state screening and characterization to greatly increase the quality and capacity of work within its Weert, Netherlands facility.

Topics: Company News Solid State